Wells Fargo’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186 | Sell |
447
-16,014
| -97% | -$6.66K | ﹤0.01% | 5983 |
|
|
2025
Q1 | $10.3K | Buy |
16,461
+362
| +2% | +$226 | ﹤0.01% | 5415 |
|
|
2024
Q4 | $26.9K | Buy |
16,099
+5,603
| +53% | +$9.36K | ﹤0.01% | 5187 |
|
|
2024
Q3 | $19.1K | Sell |
10,496
-79
| -0.7% | -$144 | ﹤0.01% | 5249 |
|
|
2024
Q2 | $63.8K | Buy |
10,575
+1,251
| +13% | +$7.54K | ﹤0.01% | 4832 |
|
|
2024
Q1 | $104K | Buy |
9,324
+1,028
| +12% | +$11.5K | ﹤0.01% | 4504 |
|
|
2023
Q4 | $124K | Buy |
8,296
+2,890
| +53% | +$43K | ﹤0.01% | 4374 |
|
|
2023
Q3 | $25.9K | Sell |
5,406
-3,627
| -40% | -$17.4K | ﹤0.01% | 5131 |
|
|
2023
Q2 | $67.8K | Buy |
9,033
+3,928
| +77% | +$29.5K | ﹤0.01% | 4985 |
|
|
2023
Q1 | $23.1K | Buy |
5,105
+3,313
| +185% | +$15K | ﹤0.01% | 5265 |
|
|
2022
Q4 | $20.2K | Buy |
1,792
+946
| +112% | +$10.7K | ﹤0.01% | 4939 |
|
|
2022
Q3 | $9K | Sell |
846
-2,718
| -76% | -$28.9K | ﹤0.01% | 5380 |
|
|
2022
Q2 | $29K | Sell |
3,564
-6,889
| -66% | -$56.1K | ﹤0.01% | 4989 |
|
|
2022
Q1 | $177K | Sell |
10,453
-4,079
| -28% | -$69.1K | ﹤0.01% | 4740 |
|
|
2021
Q4 | $312K | Buy |
14,532
+8,062
| +125% | +$173K | ﹤0.01% | 4673 |
|
|
2021
Q3 | $478K | Buy |
6,470
+5,543
| +598% | +$410K | ﹤0.01% | 4423 |
|
|
2021
Q2 | $50K | Buy |
927
+20
| +2% | +$1.08K | ﹤0.01% | 5240 |
|
|
2021
Q1 | $67K | Sell |
907
-12,556
| -93% | -$928K | ﹤0.01% | 5321 |
|
|
2020
Q4 | $1.16M | Buy |
13,463
+6,205
| +85% | +$535K | ﹤0.01% | 3856 |
|
|
2020
Q3 | $274K | Buy |
+7,258
| New | +$274K | ﹤0.01% | 4631 |
|